Signal Transduction and Targeted Therapy,
Journal Year:
2024,
Volume and Issue:
9(1)
Published: June 18, 2024
Abstract
Tumorigenesis
is
a
multistep
process,
with
oncogenic
mutations
in
normal
cell
conferring
clonal
advantage
as
the
initial
event.
However,
despite
pervasive
somatic
and
expansion
tissues,
their
transformation
into
cancer
remains
rare
event,
indicating
presence
of
additional
driver
events
for
progression
to
an
irreversible,
highly
heterogeneous,
invasive
lesion.
Recently,
researchers
are
emphasizing
mechanisms
environmental
tumor
risk
factors
epigenetic
alterations
that
profoundly
influencing
early
malignant
evolution,
independently
inducing
mutations.
Additionally,
evolution
tumorigenesis
reflects
multifaceted
interplay
between
cell-intrinsic
identities
various
cell-extrinsic
exert
selective
pressures
either
restrain
uncontrolled
proliferation
or
allow
specific
clones
progress
tumors.
by
which
induce
both
intrinsic
cellular
competency
remodel
stress
facilitate
not
fully
understood.
In
this
review,
we
summarize
genetic,
epigenetic,
external
events,
effects
on
co-evolution
transformed
cells
ecosystem
during
initiation
evolution.
A
deeper
understanding
earliest
molecular
holds
promise
translational
applications,
predicting
individuals
at
high-risk
developing
strategies
intercept
transformation.
Genome biology,
Journal Year:
2022,
Volume and Issue:
23(1)
Published: Jan. 26, 2022
Abstract
Background
Genetic
alterations
of
somatic
cells
can
drive
non-malignant
clone
formation
and
promote
cancer
initiation.
However,
the
link
between
these
processes
remains
unclear
hampers
our
understanding
tissue
homeostasis
development.
Results
Here,
we
collect
a
literature-based
repertoire
3355
well-known
or
predicted
drivers
non-cancer
evolution
in
122
types
12
tissues.
Mapping
genes
7953
pan-cancer
samples
reveals
that,
despite
large
size,
known
compendium
is
still
incomplete
biased
towards
frequently
occurring
coding
mutations.
High
overlap
exists
evolution,
although
significant
differences
emerge
their
recurrence.
We
confirm
expand
unique
properties
identify
core
evolutionarily
conserved
essential
whose
germline
variation
strongly
counter-selected.
Somatic
alteration
even
one
sufficient
to
clonal
expansion
but
not
malignant
transformation.
Conclusions
Our
study
offers
comprehensive
overview
current
genetic
events
initiating
revealing
gaps
biases
that
need
be
addressed.
The
drivers,
literature
support,
are
accessible
Network
Cancer
Genes
Healthy
Drivers
resource
at
http://www.network-cancer-genes.org/
.
Signal Transduction and Targeted Therapy,
Journal Year:
2024,
Volume and Issue:
9(1)
Published: June 18, 2024
Abstract
Tumorigenesis
is
a
multistep
process,
with
oncogenic
mutations
in
normal
cell
conferring
clonal
advantage
as
the
initial
event.
However,
despite
pervasive
somatic
and
expansion
tissues,
their
transformation
into
cancer
remains
rare
event,
indicating
presence
of
additional
driver
events
for
progression
to
an
irreversible,
highly
heterogeneous,
invasive
lesion.
Recently,
researchers
are
emphasizing
mechanisms
environmental
tumor
risk
factors
epigenetic
alterations
that
profoundly
influencing
early
malignant
evolution,
independently
inducing
mutations.
Additionally,
evolution
tumorigenesis
reflects
multifaceted
interplay
between
cell-intrinsic
identities
various
cell-extrinsic
exert
selective
pressures
either
restrain
uncontrolled
proliferation
or
allow
specific
clones
progress
tumors.
by
which
induce
both
intrinsic
cellular
competency
remodel
stress
facilitate
not
fully
understood.
In
this
review,
we
summarize
genetic,
epigenetic,
external
events,
effects
on
co-evolution
transformed
cells
ecosystem
during
initiation
evolution.
A
deeper
understanding
earliest
molecular
holds
promise
translational
applications,
predicting
individuals
at
high-risk
developing
strategies
intercept
transformation.